IMPAKT 2015: News

The latest news about the latest research presented at the IMPAKT 2015 breast cancer conference

Twitter

Follow all the news and updates about the conference on Twitter by using the hashtag #IMPAKT15

Filter

Date Title Topic
08 May 2015 IMPAKT 2015 News: Molecular Screening of Patients with Metastatic Breast Cancer Can Be Carried-Out Across EU Countries Breast cancer - Personalised medicine
07 May 2015 IMPAKT 2015 News: A Circulating Tumour Cell Liquid Biopsy May Be Used for Non-Invasive Mutational Analysis in Patients with Breast Cancer Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: Constitutively Activated STAT3 May Be a Predictive Marker for Resistance to Trastuzumab in Patients with HER2 Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Incidence of Breast Cancer Oncogenes Higher in the PIK3K/AKT Signalling Pathway than in the MAPK Pathway Breast cancer - Translational research
07 May 2015 IMPAKT 2015 News: Using a Biomarker for Neoadjuvant Bevacizumab Response to Guide Treatment Is Cost Effective in Breast Cancer Breast cancer - Bioethics, legal and economic issues - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Analysis of Large Dataset Shows Improved Concordance of Local and Central HER2 Status Breast cancer - Pathology/Molecular biology
07 May 2015 IMPAKT 2015 News: Outcome in Male Patients with Breast Cancer Varies According to Tumour Subtypes Based upon Receptor Expression Breast cancer
07 May 2015 IMPAKT 2015 News: PI3 Kinase and CDK4/6 Inhibitors Are Highly Active in ER-Positive Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: AP-2gamma Tumour Expression Is a New Biomarker for Resistance to Endocrine Therapy in Patients with Metastatic Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy
07 May 2015 IMPAKT 2015 News: Gene Expression Signatures May Signal Clinical Activity of Palbociclib in Patients with Breast Cancer Breast cancer - Translational research - Anticancer agents & Biologic therapy